Medical Condition News

RSS

Analysis of the immune landscape in mild-to-moderate COVID-19

A new study includes an analysis of plasma cytokine levels, peripheral blood immune cell composition, and SARS-CoV-2 specific Igs in COVID-19.

15 Sep 2021

Flavonoids can potentially help prevent COVID-19-induced diarrhea, study finds

A recent study published in Tropical Biomedicine determines whether flavonoids can help prevent diarrhea caused by SARS-CoV-2 infection.

15 Sep 2021

Study looks at exposure to different SARS-CoV-2 variants and immune response

Researchers compared the responses against several SARS-CoV-2 VoCs in sera from individuals exposed to variant infection, vaccination, or both.

15 Sep 2021

COVID mRNA vaccines display weakened immune response with age and diminish over time, according to new study

Researchers from Simon Fraser University in Canada decided to investigate the magnitude of immunity in mRNA vaccines for COVID-19.

15 Sep 2021

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

In a recent study, researchers investigate the possibility of using the thiazolide antiparasitic nitazoxanide for the treatment of COVID-19.

15 Sep 2021

Single protein is a key player in two very common forms of dementia, study reveals

Dementia has many faces, and because of the wide range of ways in which it can develop and affect patients, it can be very challenging to treat.

15 Sep 2021

New CDC data shows a significant rise in number of states with adult obesity prevalence

The number of states in which at least 35% of residents are obese has nearly doubled since 2018 – and disparities persist – according to new data from the Centers for Disease Control and Prevention.

15 Sep 2021

Hospitalized patients with opioid use disorder die at a rate comparable to heart attack patients

Hospitalized patients with opioid use disorder died at a rate comparable to those who suffered heart attacks within a year of hospital discharge, according to a new study from Oregon Health & Science University.

15 Sep 2021

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for Covid-19, some of the same events which have led to restricted use of the Oxford-AstraZeneca vaccine in a number of countries.

15 Sep 2021

SARS-CoV-2 can cause sustained biochemical dysregulation that results in long-COVID

This state has come to be known as long-COVID, and in a paper recently uploaded to the preprint server medRxiv* by Simjanoska et al. (September 7th, 2021) the biochemical parameters of long-COVID patients with prior mild, moderate, or severe COVID-19 that resulted in hospitalization are tracked in detail, finding a characteristically dysregulated immune and inflammatory response in the most seriously ill.

15 Sep 2021

New animated video explores how social media affects people with eating disorders

Researchers from Loughborough University have teamed up with UK charity Beat to create an animated video that explores how social media affects people with an eating disorder.

15 Sep 2021

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

Munich-based digital health company Temedica and healthcare company Roche Pharma AG have announced a joint collaboration in the field of digital support for multiple sclerosis patients.

15 Sep 2021

Liver may play a key role in the onset or progression of Alzheimer's disease

Amyloid protein made in the liver can cause neurodegeneration in the brain, according to a new study in the open-access journal PLOS Biology, by John Mamo of Curtin University in Bentley, Australia, and colleagues.

14 Sep 2021

Pregnancy complications with COVID-19

An important new article published in the Clinical Medicine Journal discusses pregnancy complicated with COVID-19.

14 Sep 2021

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

14 Sep 2021

Medical Condition News

Analysis of the immune landscape in mild-to-moderate COVID-19

Flavonoids can potentially help prevent COVID-19-induced diarrhea, study finds

Study looks at exposure to different SARS-CoV-2 variants and immune response

COVID mRNA vaccines display weakened immune response with age and diminish over time, according to new study

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Single protein is a key player in two very common forms of dementia, study reveals

New CDC data shows a significant rise in number of states with adult obesity prevalence

Hospitalized patients with opioid use disorder die at a rate comparable to heart attack patients

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

SARS-CoV-2 can cause sustained biochemical dysregulation that results in long-COVID

New animated video explores how social media affects people with eating disorders

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

Liver may play a key role in the onset or progression of Alzheimer's disease

Pregnancy complications with COVID-19

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

Gut microbiome profile could help predict patient's rheumatoid arthritis prognosis

Colorectal Cancer Project launches to improve understanding of the disease and accelerate research

New dashboard intends to drive collaborations in cancer and Covid-19 research

Researchers explore the impact of venous thromboembolism during surgery for renal cell carcinoma

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News